Postdoctoral Fellow - Cancer Genomics | GenomeWeb

Postdoctoral Fellow - Cancer Genomics

National Human Genome Research Institute at NIH
Job Location
Bethesda, MD
Job Description

Seeking a highly motivated Postdoctoral candidate with a strong background in cancer research. The overarching goal of our laboratory is to identify, and functionally characterize, somatically mutated genes that underlie the development of clinically aggressive forms of human endometrial (uterine) cancer (Nature Genetics 2012; 44:1310-5). To this end we use next-generation sequencing to decode endometrial cancer exomes and identify candidate cancer genes, followed by functional studies of the encoded mutant proteins using biochemical and cell based approaches.


Candidates should have or be very close to obtaining a PhD, and have less than two years of Postdoctoral experience. Applicants must have a strong background in cancer research, as well as expertise in computational genomics (high throughput sequence analysis) and/or molecular biology, as evidenced by peer-reviewed publications including at least one first-author publication. Excellent communication skills and fluency in both spoken and written English are essential.

How to Apply

Interested candidates should submit their curriculum vitae, a detailed letter of interest, and the names and contact information for three referees to Dr. Daphne Bell at

About Our Organization

The Intramural Research Program is on the Bethesda campus and offers a wide array of training opportunities for scientists early in their careers. The NIH is dedicated to building a diverse community in its training and employment programs.

At Science Careers, Princeton University's Julian West advises new researchers to read widely.

At Science Careers, a researcher describes how her rejuvenated postdoc science policy committee is promoting science.

Bitesize Bio's Gail Seigel offers some tips on running a low-budget lab.

The GRE isn't a good predictor of graduate school performance or productivity, according to two PLOS One studies.